Symvenu is indicated for: treatment of schizophrenia in adult patients, acute treatment of manic or mixed episodes associated with bipolar I disorder in adult patients, treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adult patients.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign Out
